Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 30, 2024
Approximately
50%
of
the
patients
with
ulcerative
colitis
(UC)
are
primarily
nonresponsive
to
anti-tumor
necrosis
factor
(TNF)
therapy
or
lose
their
responsiveness
over
time.
The
gut
microbiota
plays
an
important
role
in
resistance
UC
anti-TNF
therapy;
however,
underlying
mechanism
remains
unknown.
Here,
it
is
found
that
transplantation
fecal
from
alters
diversity
dextran
sulfate
sodium-induced
mice
and
may
affect
therapeutic
infliximab.
Furthermore,
abundances
Romboutsia
Fusobacterium
increase
tissues
who
do
not
respond
therapy.
Differentially
abundant
metabolites
mainly
enriched
nicotinate
nicotinamide
metabolism
NCM460
cells
after
nucleatum
infection.
Mechanistically,
F.
promotes
adenine
dinucleotide
(NAD+)
salvage
pathway
by
upregulating
NAMPT
expression,
which
subsequently
leads
activation
p38
mitogen-activated
protein
kinase
(MAPK)
signaling
secretion
inflammatory
factors,
ultimately
inhibiting
response
drugs.
These
findings
demonstrate
can
influence
highlight
potential
targeting
its
associated
pathways
for
preventing
treating
drug
UC.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(14), P. 2343 - 2343
Published: July 19, 2024
Hesperetin
(HT)
is
a
type
of
citrus
flavonoid
with
various
pharmacological
activities,
including
anti-tumor,
anti-inflammation,
antioxidant,
and
neuroprotective
properties.
However,
the
role
mechanism
HT
in
ulcerative
colitis
(UC)
have
been
rarely
studied.
Our
study
aimed
to
uncover
beneficial
effects
its
detailed
UC.
Experimental
was
induced
by
2.5%
dextran
sodium
sulfate
(DSS)
for
seven
days.
ameliorated
DSS-induced
mice,
showing
marked
improvement
weight
loss,
colon
length,
colonic
pathological
severity,
levels
TNFα
IL6
serum.
A
combination
informatics,
network
pharmacology,
molecular
docking
identified
eight
key
targets
multi-pathways
influenced
As
highlight,
experimental
validation
demonstrated
that
PTGS2,
marker
ferroptosis,
along
other
indicators
ferroptosis
(such
as
ACSL4,
Gpx4,
lipid
peroxidation),
were
regulated
vivo
vitro.
Additionally,
supplement
increased
diversity
gut
microbiota,
decreased
relative
abundance
Proteobacteria
Gammaproteobacteria,
restored
bacteria
(Lachnospiraceae_NK4A136_group
Prevotellaceae_UCG-001).
In
conclusion,
an
effective
nutritional
against
suppressing
modulating
microbiota.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(10), P. 5453 - 5453
Published: May 17, 2024
Gut
microbiota
imbalances
have
a
significant
role
in
the
pathogenesis
of
Inflammatory
Bowel
Disease
(IBD)
and
Non-Alcoholic
Fatty
Liver
(NAFLD).
Herein,
we
compared
gut
microbial
composition
patients
diagnosed
with
either
IBD
or
NAFLD
combination
both.
Seventy-four
participants
were
stratified
into
four
groups:
IBD-NAFLD,
IBD-only,
NAFLD-only
patients,
healthy
controls
(CTRLs).
The
16S
rRNA
was
sequenced
by
Next-Generation
Sequencing.
Bioinformatics
statistical
analysis
performed.
Bacterial
α-diversity
showed
lower
value
when
IBD-only
group
to
other
groups
particularly
against
IBD-NAFLD
group.
β-diversity
also
difference
among
groups.
higher
Bacteroidetes/Firmicutes
ratio
found
only
comparing
CTRLs.
Comparing
group,
decrease
differential
abundance
Subdoligranulum,
Parabacteroides,
Fusicatenibacter
found.
groups,
there
Alistipes,
Odoribacter,
Sutterella,
Lachnospira.
An
inverse
relationship
comparison
between
shown.
For
first
time,
singularity
has
been
shown,
implying
potential
signature
mainly
influenced
inflammation.
Clinical and Experimental Medicine,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 2, 2025
Vedolizumab
(VDZ)
is
a
humanized,
gut-selective
biologic
used
in
the
treatment
of
ulcerative
colitis
(UC).
However,
data
on
predictive
factors
for
response
are
limited.
This
study
aims
to
develop
nomogram
predict
VDZ
responsiveness
UC.
We
retrospectively
collected
clinical
from
patients
with
moderate-to-severe
active
UC
who
received
induction
therapy
at
Chongqing
General
Hospital
December
2020
March
2024.
Full-slide
images
colon
biopsies
prior
were
analyzed
quantify
mean
mucosal
eosinophil
density
(MMED).
Based
14-week
post-treatment,
categorized
into
responsive
and
non-responsive
groups.
In
total,
84
analyzed,
58
responding
26
not
responding.
Significant
differences
observed
pathological
indices,
MMED
showing
statistically
significant
difference
between
groups
(p
<
0.001).
Serum
biomarkers,
including
C-reactive
protein
(CRP),
also
showed
(P
=
0.015),
as
did
CRP/albumin
(CRP/ALB)
ratio
0.018).
Additionally,
UCEIS
scores
differed
significantly
0.025).
Independent
risk
identified
through
multivariate
logistic
regression
analysis
establish
model,
presented
nomogram.
The
area
under
curve
(AUC)
combined
CRP
model
was
0.867
(95%
CI:
0.781–0.953,
p
0.001),
indicating
high
accuracy
predicting
efficacy.
These
easily
accessible
even
primary
healthcare
settings,
allowing
our
support
improved
decisions
patients.
Foods,
Journal Year:
2025,
Volume and Issue:
14(7), P. 1181 - 1181
Published: March 28, 2025
Addressing
the
escalating
global
burdens
of
inflammatory
bowel
disease
and
antimicrobial
resistance
demanded
innovative
food-based
approaches
to
fortify
gut
health
suppress
pathogens.
We
introduced
a
novel
edible
probiotic,
Enterococcus
faecalis
HY0110,
isolated
from
marine
Thunnus
thynnus.
Through
comprehensive
in
vitro,
vivo,
metabolomic
analyses,
we
demonstrated
its
superior
antibacterial
effects
compared
Lactobacillus
rhamnosus
GG,
along
with
significantly
enhanced
antioxidant
free-radical
scavenging
capacities.
Notably,
elevated
acetic
acid
production
strongly
correlated
efficacy
(R
≥
0.999).
HY0110
also
exerted
antiproliferative
on
HT-29
colorectal
cancer
cells
by
attenuating
β-catenin
BCL-2
expression
while
upregulating
pro-apoptotic
markers
P62
c-PARP.
In
DSS-induced
colitis
model,
alleviated
inflammation,
restored
microbial
homeostasis,
deterministic
processes
community
assembly
dynamics.
Furthermore,
fermenting
Periplaneta
americana
powder
triggered
extensive
metabolic
remodeling,
notably
668.73-fold
rise
astragaloside
A,
plus
increases
L-Leucyl-L-Alanine,
S-lactoylglutathione,
16,16-dimethyl
prostaglandin
A1.
These
shifts
diminished
harmful
components
amplified
essential
amino
acids
peptides
bolster
immune
modulation,
redox
balance,
anti-inflammatory
responses.
This
work
established
transformative
paradigm
for
utilizing
probiotics
entomological
substrates
functional
foods,
presenting
strategic
pathways
precision
nutrition
management.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 9, 2025
Inorganic
dietary
nanoparticles
(IDNPs)
are
frequently
utilized
as
food
additives
and
in
packaging,
resulting
their
exposure
becoming
a
substantial
yet
often
overlooked
concern
for
patients
with
inflammatory
bowel
disease
(IBD).
Considering
that
impaired
intestinal
barrier
function
plays
central
role
the
pathogenesis
of
IBD,
this
review
concentrates
on
roles
mechanisms
IDNPs
(physical,
chemical,
biological,
immune
barriers)
IBD
patients.
Previous
studies
have
shown
different
types
varying
effects
animals
diverse
states.
In
context,
factors
such
source,
size,
shape,
dosage,
duration
action
nanoparticles,
well
species,
gender,
habits,
age
animals,
significantly
influence
research
outcomes.
Future
should
undertake
more
comprehensive
explorations
into
sources
properties
Toxics,
Journal Year:
2025,
Volume and Issue:
13(5), P. 331 - 331
Published: April 23, 2025
Bisphenol
A
(BPA),
a
widespread
environmental
contaminant
used
in
plastics
and
resins,
poses
significant
health
risks
due
to
its
endocrine-disrupting
properties
potential
for
inducing
intestinal
toxicity.
This
study
explored
the
toxicological
effects
of
BPA
on
small
intestine
rats,
focusing
duodenum,
jejunum,
ileum.
Histopathological
evaluation
revealed
that
duodenum
experienced
most
severe
structural
damage,
including
villous
atrophy,
epithelial
shedding,
mitochondrial
degeneration.
exposure
disrupted
oxidative
stress
homeostasis
by
reducing
superoxide
dismutase
activity
increasing
malondialdehyde
levels,
along
with
upregulating
antioxidant-related
genes
like
GPX2
HO-1
upregulated,
indicating
lipid
peroxidation
damage.
Inflammatory
markers
such
as
IL-1
NFκB
were
significantly
highlighting
an
active
inflammatory
response
cell
apoptosis.
also
altered
metabolism,
increased
expression
lipogenic
SREBP-1c
FAS,
metabolic
dysregulation.
Fecal
microbiota
analysis
reduced
α-diversity,
enrichment
pathogenic
taxa
Escherichia-Shigella,
depletion
beneficial
genera
Lachnospiraceae
NK4A136
group,
exacerbating
gut
inflammation
barrier
dysfunction.
These
findings
suggest
BPA-induced
damage
is
driven
stress,
inflammation,
dysbiosis,
jejunum
being
more
vulnerable
segments.
Precision Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
7(3)
Published: July 24, 2024
Abstract
Inflammatory
bowel
disease
(IBD)
is
a
chronic
inflammatory
disorder
of
the
gastrointestinal
tract,
and
its
pathogenesis
believed
to
be
associated
with
an
imbalance
between
commensal
organisms
intestinal
immune
system.
This
significantly
influenced
by
microbiota
metabolites
plays
critical
role
in
maintaining
mucosal
homeostasis.
However,
disturbances
cause
dysregulated
responses
consequently
induce
inflammation.
Recent
studies
have
illustrated
roles
IBD
underscored
potential
precision
diagnosis
therapy.
work
summarises
recent
progress
this
field
particularly
focuses
on
application
diagnosis,
prognosis
assessment,
treatment
effectiveness
evaluation,
therapeutic
management
IBD.
Pain and Therapy,
Journal Year:
2024,
Volume and Issue:
13(6), P. 1447 - 1469
Published: Oct. 28, 2024
Abdominal
pain
is
a
major
symptom
of
inflammatory
bowel
disease
(IBD),
including
Crohn's
and
ulcerative
colitis,
has
significant
impact
on
patients'
quality
life.
Given
the
evolving
understanding
IBD
pathology
management
strategies,
there
an
urgent
need
to
review
recent
research
findings.
In
this
review,
we
have
analyzed
epidemiology,
pathophysiology,
abdominal
in
over
past
decade.
We
draw
current
literature
highlight
emerging
trends,
challenges,
advances
field.
By
synthesizing
key
findings,
provides
insights
into
complex
interplay
between
pain,
progression,
therapeutic
interventions
for
IBD.
Metabolites,
Journal Year:
2024,
Volume and Issue:
14(5), P. 269 - 269
Published: May 7, 2024
Metabolomics
can
allow
for
the
comprehensive
identification
of
metabolites
within
biological
systems,
at
given
time
points,
in
physiological
and
pathological
conditions.
In
last
few
years,
metabolomic
analysis
has
gained
popularity
both
human
veterinary
medicine,
showing
great
potential
novel
applications
clinical
activity.
The
aim
applying
metabolomics
practice
is
understanding
mechanisms
underlying
conditions
influence
certain
stimuli
(i.e.,
drugs,
nutrition,
exercise)
on
body
attempt
identifying
biomarkers
that
help
diagnosis
diseases.
Proton
Nuclear
Magnetic
Resonance
spectroscopy
(